News

Media and Press Releases

Oct 17, 2022 | Eterna

Eterna Therapeutics Completes Name Change, Acquires Option to License iPSC-Derived NK and T Cell Therapies from Exacis Biotherapeutics

Jul 19, 2022 | Businesswire

OWYN Announces Funding Round Led by Purchase Capital to Accelerate National Expansion

Jun 7, 2022 | Press Release

Brooklyn ImmunoTherapeutics Announces Board Changes

Mar 25, 2021 | Press Release

Brooklyn ImmunoTherapeutics Completes Reverse Merger with NTN Buzztime

Aug 13, 2020 | Press Release

NTN Buzztime, Inc. and Brooklyn ImmunoTherapeutics LLC Enter Into Definitive Merger Agreement